AstraZeneca has unveiled plans to invest £2bn in Beijing months after Chinese authorities detained the company’s local boss ...

AstraZeneca plans to build a $2.5 billion research and development center in Beijing, the Britain-based multinational ...

British pharmaceutical giant AstraZeneca announced on Friday that it will invest $2.5 billion in a research and development ...

The pharmaceutical firm expects its workforce in Beijing to grow to 1,700 employees and is launching a JV with BioKangtai to ...

Investment includes agreements with Harbour BioMed, Syneron Bio and BioKangtai
.

AstraZeneca said on Friday it will spend $2.5 billion on a research and development hub in Beijing, as the drugmaker ...

HONG KONG, LONDON] Ever since AstraZeneca shocked investors in October with news its China chief was under investigation, the ...

Multinational pharmaceutical company AstraZeneca is bullish about China's role as a global innovation powerhouse, underpinned ...

Beijing: AstraZeneca has announced an investment of USD 2.5 billion in Beijing to establish its sixth global strategic R&D ...

AstraZeneca announced on Friday an investment of $2.5 billion in Beijing to establish the pharmaceutical company's sixth ...

Investing.com -- AstraZeneca (NASDAQ: AZN) Plc’s Chief Executive Officer, Pascal Soriot, has warned that Europe is rapidly losing its pharmaceutical innovation edge to China. He voiced his concerns ...